Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens-Reference-Cited by-同舟云学术

Structure-Based Design and Antigenic Validation of Respiratory Syncytial Virus G Immunogens

Published:2022-04-13 Issue:7 Volume:96 Page:
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:J Virol

Author:

Nuñez Castrejon Ana M.¹^ORCID,O’Rourke Sara M.²^ORCID,Kauvar Lawrence M.³^ORCID,DuBois Rebecca M.²^ORCID

Affiliation:

1. Department of Microbiology and Environmental Toxicology, University of California Santa Cruz, Santa Cruz, California, USA

2. Department of Biomolecular Engineering, University of California Santa Cruz, Santa Cruz, California, USA

3. Trellis Bioscience, Inc., Redwood City, California, USA

Abstract

Respiratory syncytial virus (RSV) causes severe lower respiratory diseases of children, the elderly, and immunocompromised populations. There currently are no FDA-approved RSV vaccines.

Funder

HHS | NIH | National Institute of Allergy and Infectious Diseases

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/jvi.02201-21

Reference67 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

2. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: Systematic review and meta–analysis

3. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

4. Respiratory Syncytial Virus Infection in Older Adults: An Under-Recognized Problem

5. Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Responses and Protection Profiles in Mice Induced by Subunit Vaccine Candidates Based on the Extracellular Domain Antigen of Respiratory Syncytial Virus G Protein Combined with Different Adjuvants;Vaccines;2024-06-19

2. A Phase 2 random, double-blind, placebo-controlled study of the safety and immunogenicity of a recombinant G protein-based respiratory syncytial virus vaccine in healthy older adults;2023-10-27

3. Respiratory syncytial virus infection and novel interventions;Nature Reviews Microbiology;2023-07-12

4. Immunogenicity and protective efficacy of an RSV G S177Q central conserved domain nanoparticle vaccine;Frontiers in Immunology;2023-06-29

5. Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection;Frontiers in Immunology;2023-06-09